{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:43:00Z","timestamp":1759693380175,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.110084","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T02:15:49Z","timestamp":1594260949000},"page":"110084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate"],"prefix":"10.1016","volume":"143","author":[{"given":"Rituparna","family":"Acharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110084_b0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health \u2014 The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int J Infect Diseases"},{"key":"10.1016\/j.mehy.2020.110084_b0010","series-title":"Medical microbiology","first-page":"587","article-title":"57 - Coronaviruses","author":"Peiris","year":"2012"},{"issue":"5567","key":"10.1016\/j.mehy.2020.110084_b0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.1068999","article-title":"A system for stable expression of short interfering RNAs in mammalian cells","volume":"296","author":"Brummelkamp","year":"2002","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.mehy.2020.110084_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.109928","article-title":"The recent progresses in shRNA-nanoparticle conjugate as a therapeutic approach","volume":"104","author":"Acharya","year":"2019","journal-title":"Mater Sci Eng, C"},{"key":"10.1016\/j.mehy.2020.110084_b0025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jddst.2019.05.008","article-title":"Intercalation of shRNA-plasmid in Mg\u2013Al layered double hydroxide nanoparticles and its cellular internalization for possible treatment of neurodegenerative diseases","volume":"52","author":"Acharya","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"8","key":"10.1016\/j.mehy.2020.110084_b0030","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev"},{"issue":"1","key":"10.1016\/j.mehy.2020.110084_b0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12034-019-1976-0","article-title":"An in vitro comparative study of layered-double hydroxide nanoconjugate in the delivery of small interference and short-hairpin ribonucleic acid","volume":"43","author":"Acharya","year":"2019","journal-title":"Bull Mater Sci"},{"key":"10.1016\/j.mehy.2020.110084_b0040","first-page":"141","article-title":"Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown","volume":"629","author":"Moore","year":"2010","journal-title":"Methods Mol Biol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720319411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720319411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:25:45Z","timestamp":1759692345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720319411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":8,"alternative-id":["S0306987720319411"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110084","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110084"}}